MEDARTIS HOLDING AG Namen AKT (Switzerland)
MEDARTIS HOLDING AG Namen AKT (Sw.../ CH0386200239 /
MDRSF
|
10/21/2024 4:51:24 PM
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
66.6800USD
|
-
|
500
Turnover: 33,340 |
-Bid Size: - |
-Ask Size: - |
762.26 mill.USD |
- |
- |
Business description
As an innovation leader, Medartis promotes technologies and solutions for osteosynthesis in the fields of cranio-maxillofacial surgery as well as upper and lower extremities. In close cooperation with international surgeons and scientists from leading clinics and universities. Developed and produced at the headquarters in Basel/Switzerland.
Management board & Supervisory board
| CEO |
| Matthias Schupp |
| Management board |
| Dirk Kirsten, Manuel Schaer, Anthony Durieux-Menage, Mareike Loch, Mario Della Casa |
| Supervisory board |
| Marco Gadola, Dr h.c. Thomas Straumann, Damien Tappy, Willi Miesch, Nadia Tarolli Schmidt, Ciro Roemer, Martha Shadan, Jennifer Dean |
Company data
| Name: |
Medartis Holding AG |
| Address: |
Hochbergstraße 60E,CH-4057 Basel |
| Phone: |
+41-61-633-34-34 |
| Fax: |
+41-61-633-34-00 |
| E-mail: |
info@medartis.com
|
| Internet: |
www.medartis.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
- |
| IPO date: |
3/23/2018 |
Company calendar
|
CW 12 | 3/18/2025
4th Quarter/Annual Report
|
|
CW 17 | 4/25/2025
General Shareholder Meeting
|
